Experience with SGLT2 Inhibitors in Patients with Single Ventricle Congenital Heart Disease and Fontan Circulatory Failure
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Experience with SGLT2 Inhibitors in Patients with Single Ventricle Congenital Heart Disease and Fontan Circulatory Failure
Authors
Keywords
-
Journal
PEDIATRIC CARDIOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-11-03
DOI
10.1007/s00246-023-03332-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Considerations for Advanced Heart Failure Consultation in Individuals With Fontan Circulation: Recommendations From ACTION
- (2023) Adam M. Lubert et al. Circulation-Heart Failure
- Impact of dapagliflozin on cardiac remodelling in patients with chronic heart failure: the DAPA‐MODA study
- (2023) Domingo A. Pascual‐Figal et al. EUROPEAN JOURNAL OF HEART FAILURE
- Safety and Treatment Experience With Sodium/glucose Cotransporter-2 Inhibitors in Adult Patients With Congenital Heart Disease
- (2023) JOSHUA SAEF et al. JOURNAL OF CARDIAC FAILURE
- The Fontan Circulation: From Ideal to Failing Hemodynamics and Drug Therapies for Optimization
- (2022) Nils Perrin et al. CANADIAN JOURNAL OF CARDIOLOGY
- 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
- (2022) Paul A. Heidenreich et al. CIRCULATION
- Heart failure in adults with congenital heart disease
- (2022) Margarita Brida et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Early Clinical Experience with Dapagliflozin in Children with Heart Failure
- (2022) David M. Newland et al. PEDIATRIC CARDIOLOGY
- Cardiorenal protection of SGLT2 inhibitors—Perspectives from metabolic reprogramming
- (2022) Yue-Ming Gao et al. EBioMedicine
- Feasibility and Safety of Sodium Glucose Cotransporter-2 Inhibitors in Adults with Heart Failure after the Fontan Procedure
- (2022) Jun Muneuchi et al. Case Reports in Cardiology
- Universal Definition and Classification of Heart Failure
- (2021) Biykem Bozkurt et al. JOURNAL OF CARDIAC FAILURE
- Cardiac Energy Metabolism in Heart Failure
- (2021) Gary D. Lopaschuk et al. CIRCULATION RESEARCH
- Modes of late mortality in patients with a Fontan circulation
- (2020) Chin Poh et al. HEART
- Renal protection: a leading mechanism for cardiovascular benefit in patients treated with SGLT2 inhibitors
- (2020) Davide Margonato et al. HEART FAILURE REVIEWS
- Evaluation and Management of the Child and Adult With Fontan Circulation: A Scientific Statement From the American Heart Association
- (2019) Jack Rychik et al. CIRCULATION
- Metabolic Remodeling in the Pressure‐Loaded Right Ventricle: Shifts in Glucose and Fatty Acid Metabolism—A Systematic Review and Meta‐Analysis
- (2019) Anne‐Marie C. Koop et al. Journal of the American Heart Association
- Chronic kidney damage in the adult Fontan population
- (2018) D. Lee et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Clinical Phenotypes of Fontan Failure: Implications for Management
- (2016) Wendy M. Book et al. Congenital Heart Disease
- The STARBRITE Trial: A Randomized, Pilot Study of B-Type Natriuretic Peptide–Guided Therapy in Patients With Advanced Heart Failure
- (2011) Monica R. Shah et al. JOURNAL OF CARDIAC FAILURE
- Use of Amino-Terminal Pro–B-Type Natriuretic Peptide to Guide Outpatient Therapy of Patients With Chronic Left Ventricular Systolic Dysfunction
- (2011) James L. Januzzi et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now